10th International Workshop on HIV & Aging

New York , NY
Add to Calendar 2019-10-10 08:00 2019-10-11 17:00 America/Los_Angeles 10th International Workshop on HIV & Aging

We are pleased to welcome you to the 10th International Workshop on HIV & Aging, which will be held in on 10-11 October 2019, in New York City, NY.

The integration of antiretroviral therapy (ART) into HIV care has dramatically extended the life expectancy of those living with HIV. The longer life expectancy of people with HIV infection is changing the demographics of the HIV epidemic and currently, more than one-half of the people living with HIV are age 45 or older. Recent estimates in Europe suggest that more than 70% of those with HIV will be over the age of 50 by 2030, with a greater burden of comorbidities and the associated treatments. In comparison to similar HIV-uninfected populations, HIV-infected persons, even when on effective ART, experience an excess of morbidity and mortality. Persons on ART rarely die from complications of AIDS, but instead have early onset of aging complications including neurocognitive decline, osteoporosis and fractures, impaired physical function, frailty, and falls. The high priority on understanding the interaction between age and HIV infection is illustrated by recent summary reports from the HIV and Aging Consensus Project in the Journal of the American Geriatrics Society and ongoing NIH Program Announcements in “Multidisciplinary Studies of HIV/AIDS and Aging”, in addition to strong voices in the community.

, New York , NY See map: Google Maps

We are pleased to welcome you to the 10th International Workshop on HIV & Aging, which will be held in on 10-11 October 2019, in New York City, NY.

The integration of antiretroviral therapy (ART) into HIV care has dramatically extended the life expectancy of those living with HIV. The longer life expectancy of people with HIV infection is changing the demographics of the HIV epidemic and currently, more than one-half of the people living with HIV are age 45 or older. Recent estimates in Europe suggest that more than 70% of those with HIV will be over the age of 50 by 2030, with a greater burden of comorbidities and the associated treatments. In comparison to similar HIV-uninfected populations, HIV-infected persons, even when on effective ART, experience an excess of morbidity and mortality. Persons on ART rarely die from complications of AIDS, but instead have early onset of aging complications including neurocognitive decline, osteoporosis and fractures, impaired physical function, frailty, and falls. The high priority on understanding the interaction between age and HIV infection is illustrated by recent summary reports from the HIV and Aging Consensus Project in the Journal of the American Geriatrics Society and ongoing NIH Program Announcements in “Multidisciplinary Studies of HIV/AIDS and Aging”, in addition to strong voices in the community.